NIH Scientists Combine Technologies to View the Retina in Unprecedented Detail
By combining two imaging modalities investigators at NEI can see live neurons, epithelial cells and blood vessels deep in the eye’s light-sensing retina.
Eyes of CJD Patients Show Evidence of Prions
NIH scientists and their colleagues have found evidence of the infectious agent of sporadic Creutzfeldt-Jakob disease (CJD) in the eyes of deceased CJD patients.
Clinical Trial of Ebola Treatments Begins in DRC
An international research team has begun patient enrollment in a clinical trial testing multiple investigational Ebola therapies in the Democratic Republic of the Congo (DRC).
NIH To Evaluate Effectiveness of Male Contraceptive Skin Gel
A clinical trial funded by NIH will evaluate a male contraceptive gel for its ability to prevent pregnancy. The gel formulation was developed by the Population Council and NICHD. The Population Council will collaborate with NIH to conduct the study in NICHD’s Contraceptive Clinical Trials Network.
Myo-Inositol Unlikely to Reduce Risk of Eye Condition in Preterm Infants
Contrary to earlier study results, the vitamin-like substance myo-inositol does not appear to prevent a potentially blinding complication of preterm birth and may even reduce rates of survival among preterm infants.
Gut Bacteria May Control Movement
NINDS-supported research, published in Nature, suggests that gut bacteria may control movement in fruit flies and identify the neurons involved in this response.
Researchers Identify Immune Culprits Linked to Bone Loss in Gum Disease
An unhealthy population of microbes in the mouth triggers specialized immune cells that inflame and destroy tissues, leading to the type of bone loss associated with a severe form of gum disease, according to a new study.
Iodine Deficiency May Reduce Pregnancy Chances
Women with moderate to severe iodine deficiency may take longer to achieve a pregnancy, compared to women with normal iodine levels, according to a study by researchers at NIH.
Stem Cell Transplant for Severe Scleroderma Improves Survival, Quality of Life
New clinical trial findings show that a therapeutic regimen involving transplantation of a person’s own blood-forming stem cells can improve survival and quality of life for people with severe scleroderma.